Fifth Third Bancorp
SAGE

Fifth Third Bancorp’s Sage Therapeutics SAGE Stock Holding History

Fifth Third Bancorp’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-84
Closed -$766 – 2755
2025
Q2 		$766 Buy
+84
New +$618 ﹤0.01% 2457
2019
Q4 		– Sell
-31
Closed -$4K – 2328
2019
Q3 		$4K Buy
+31
New +$5.19K ﹤0.01% 1972
2015
Q4 		– Sell
-11
Closed – – 2857
2015
Q3 		$0 Buy
+11
New +$678 ﹤0.01% 2999

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Fifth Third Bancorp's SAGE Position: Q3 2025 in Review

Fifth Third Bancorp sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 84 shares — an estimated $766 sold.

Fifth Third Bancorp first reported a position in SAGE in Q3 2015 and held it in 3 quarters. The position peaked at $4K in Q3 2019. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Fifth Third Bancorp reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Fifth Third Bancorp sold 84 Sage Therapeutics shares in Q3 2025, an estimated $766.
  • Fifth Third Bancorp first reported a position in Sage Therapeutics in Q3 2015 and held it in 3 quarters.
  • Fifth Third Bancorp's Sage Therapeutics position peaked at $4K in Q3 2019.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Fifth Third Bancorp's 13F filing for Q3 2025, filed 7 Nov 2025.